AzTrials
AzTrials

Depression, PostpartumNCT02538497

The Northern Babies Longitudinal Study

A study testing The Newborn Behavioral Observation (NBO) and Routine care in people with Depression, Postpartum, run by University of Tromso at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Postpartum depression (PPD) is a prevalent disorder. Studying the factors related to PPD will help to identify families at risk and provide preventive interventions. This can in turn improve the developmental trajectories for the children. Several previous studies have investigated risk factors for PPD. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Depression, Postpartum
What is being tested?
The Newborn Behavioral Observation (NBO) and Routine care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
350 participants
Where
1 siteNorway
Study dates
Nov 2015to Dec 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Pregnant woman and expecting fathers
  • Speak Norwegian

Who cannot join

  • Do not speak Norwegian

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • UiT The Arctic University of Norway

    Tromsø

Other trials in Norway

About this study

Official title: The Northern Babies Longitudinal Study: Predicting Postpartum Depression and Improving Parent-infant Interaction With The Newborn Behavioral Observation

Postpartum depression (PPD) is a prevalent disorder. Studying the factors related to PPD will help to identify families at risk and provide preventive interventions. This can in turn improve the developmental trajectories for the children. Several previous studies have investigated risk factors for PPD. However, few studies have focused on cognitive vulnerability factors. The first aim of the present study is to explore a range of protective and risk factors, including cognitive factors, for PPD, parent-infant interactions and child development. The second aim of the study is to evaluate the effectiveness of The Newborn Behavioral Observation (NBO) as a universal preventive intervention delivered in routine practice. The NBO is a brief relationship-enhancing intervention that may reduce depressive symptomatology in mothers.

Read the detailed description

Aims

The present study has three broad aims:

  1. Examine key pre- and postnatal predictors related to parental functioning: a) parental depression, anxiety, and stress, b) parental reflective functioning in relation to the infant, and c) parent-infant attachment style.
  2. Examine key pre- and postnatal predictors related to interaction and developmental problems in the child: a) difficulties in parent-infant interaction in the first 4 months post-delivery, and b) infant's cognitive, communicative and motor development, signs of sustained withdrawal behaviour, and heart-rate variability at 6 months post-delivery.
  3. Evaluate the effectiveness of the NBO as a universal preventive intervention delivered in routine practice as compared to standard care, on:
  • Parental outcomes (depressive symptoms, parenting stress, reflective functioning, attachment to the infant),
  • Relational outcomes (emotional availability in parent-child interaction), and
  • Infant outcomes (cognitive, communicative and motor development at 6 months post-delivery, heart-rate variability).

Predictor variables include some well-known vulnerability factors for developing PPD (e.g., depression symptoms in pregnancy, adult attachment style, relationship satisfaction and life stress), but the main focus in the observational part of the research project is on cognitive vulnerability factors such as early maladaptive schemas, repetitive negative thinking, rumination, implicit attitudes and cognitive processing of emotionally valenced infant facial information.

Study design This is a longitudinal observational study with an intervention. The observational part of the study will use a prospective cohort design. The effect of the intervention will be evaluated using a non-randomized cluster controlled design, since neither cluster nor individual randomization is feasible in this routine practice setting. An intervention group receiving NBO (families belonging to two well-baby clinics in Tromsø municipality) will be compared with a control group (families at the remaining four well-baby clinics in Tromsø) receiving care as usual.

Recruitment All pregnant women and expecting fathers who speak Norwegian are eligible for inclusion in the study. Between autumn 2015 and autumn 2018 approximately 200 families will be recruited by midwifes and by general practitioners (GPs) in the municipality of Tromsø, which is the 9th largest municipality in Norway (~73000 inhabitants; 78). There are approximately 1000 births a year in Tromsø municipality. Based on the experiences from a comparable study, "Little in Norway" (79), the recruitment of 200 families within the project period is considered feasible.

The participants will be recruited in (approximately) week 16 of gestation. At recruitment, women will be given written information about the study and a flyer with an inquiry to be contacted by the research team. If the child's father is not present, the mother is encouraged to inform him about the study. The health worker informs the research team who contacts the women to plan a meeting with them and their partners, preferable between week 16 and 22 of gestation. In this meeting, the prospective parents are given detailed information about the study and are invited to sign an informed consent to participate. In addition, at 4 months post-delivery the parents will be asked to sign an informed consent to obtain birth related information from the birth record.

Power calculations/statistical analysis The sample size is calculated on the basis of differences between intervention group and standard care group on the Edinburgh Postnatal Depression Scale (EPDS) maternal score, the Parenting Stress Index (PSI-PD), the Parental Reflective Functioning Scale (PRFQ) and the Maternal Postnatal Attachment Scale (MPAS) 6 weeks post-delivery. Based on the pilotstudy by Nugent et al. (69) and some regression to the mean, we expect a small to medium effect size (f2 = .07). A MANOVA with the four aforementioned outcome variables can detect a difference between the groups with a power of .80 given a group sizes of N = 176. With an estimated dropout of 10 %, a group size of 200 will be recruited. The estimation is based on an α-level of .05.

Procedure For the observational part of the study, assessments will be performed at six time points (see Table 1): During gestational week 16 - 22 (Step 1), 24 - 30 (Step 2) and 31 (Step 3), and at 6 weeks (Step 4), 4 months (Step 5) and 6 months (Step 6) post-delivery. For the intervention study, pre-intervention measures will be collected at Step 3, post-intervention measures at Step 4 and follow-up measures at Step 5 and 6. Since the families will receive the first NBO already two-days post-delivery, no pre-test assessment can be obtained for the interaction and infant measures. Hence, analyses of intervention effects will be based on differences between groups at 4 and 6 months post-delivery controlling for relevant covariates. The data is collected using online questionnaires, computerized cognitive tests, video-filmed observations of mother-infant interactions, and a standardised test of the child's cognitive, communicative and motor development (Bayley Scales of Infant and Toddler Development; 80).

Being tested
The Newborn Behavioral Observation (NBO), Routine care
Keywords
NBO, The Newborn Behavioral Observation, postpartum depression, postnatal depression, child development, parent-child interaction
Medical subject headings
Depression, Postpartum

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The Newborn Behavioral Observation (NBO)Behavioural

    Also called NBO

    The Newborn Behavioral Observation (NBO) is a flexible parental guidance methodology which takes between 20 and 40 minutes to administer. It consists of 18 neurobehavioral observations which give a profile of the infant´s behavioral repertoire along the dimensions: attentional-interactional, autonomic, motor and state organization.

    The intervention group will receive 3 NBO consultations: 1) Routine care plus the NBO at the hospital within two days post-delivery; 2) Routine home visit plus the NBO by a public health nurse when the infant is 7-10 days old; and 3) NBO at the well-baby clinic when the infant is about 4 weeks old.

  • Routine careBehavioural

    The control group will receive routine care. Between 7 and 10 days after birth a public health nurse routinely visits the family at home. Six weeks after birth, the mother and the infant visit the well-baby clinic

Study groups in NCT02538497
Study groupRoleWhat they receive
NBO plus routine careExperimentalThe Newborn Behavioral Observation
Receives: Behavioral: The Newborn Behavioral Observation (NBO); Behavioral: Routine care
Routine careOtherNot described
Receives: Behavioral: Routine care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Levels of postpartum depression

    Mothers and fathers self-reported levels of postpartum depression measured with the Edinburgh Postnatal Depression Scale.

    Measured: Six weeks postpartum

Secondary outcomes (13)
  1. Levels of postpartum depression

    Mothers and fathers self-reported levels of postpartum depression measured with the Edinburgh Postnatal Depression Scale.

    Measured: Four months postpartum

  2. Levels of postpartum depression

    Mothers and fathers self-reported levels of postpartum depression measured with the Edinburgh Postnatal Depression Scale.

    Measured: Six months postpartum

  3. Parental reflective functioning

    Mothers and fathers self-reported parental reflective functioning measured with the Parental Reflective Functioning Questionnaire.

    Measured: Six weeks postpartum

  4. Parental reflective functioning

    Mothers and fathers self-reported parental reflective functioning measured with the Parental Reflective Functioning Questionnaire.

    Measured: Four months postpartum

  5. Bonding between parent and child

    Self-reported quality of bonding between parent and child measured with Maternal Postnatal Attachment Scale/Paternal Postnatal Attachment Scale.

    Measured: Six weeks postpartum

  6. Bonding between parent and child

    Self-reported quality of bonding between parent and child measured with Maternal Postnatal Attachment Scale/Paternal Postnatal Attachment Scale.

    Measured: Four months postpartum

  7. Parent-child interaction

    Parent-child interaction will be rated on the basis of 15-30 minutes videotaped episodes of parent-infant play interaction.

    Measured: Four months postpartum

  8. Parental stress

    Self-reported measure of parental stress.

    Measured: Six weeks postpartum

  9. Parental stress

    Self-reported measure of parental stress.

    Measured: Four months postpartum

  10. A composite measure of the infant´s temperament

    Parents report of infant´s sensitivity, general activity, frustration tolerance, adaptability, regularity, and soothability.

    Measured: Six months postpartum

  11. Infants social withdrawal behaviour

    Assessment of the infant's social withdrawal behaviour with The Alarm Distress Baby Scale.

    Measured: Six months postpartum

  12. Infant cognitive, communicative and motor development

    Assessment of the infant's cognitive, communicative and motor development with The screening test version of Bayley Scales of Infant and Toddler Development

    Measured: Six months postpartum

  13. Heart rate variability

    Mothers and infants heart rate variability will be measured with a wireless and unobtrusive electrocardiogram (ECG) equipment.

    Measured: Six months postpartum

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Sep 2015 (estimated)
  2. Study startNov 2015
  3. Primary completionDec 2018
  4. Study completionDec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
350 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02538497
Sponsor's protocol ID
2015/614REK nord
Status last verified
Apr 2019
First submitted
4 Aug 2015
Last updated
17 May 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Hoifodt RS, Nordahl D, Landsem IP, Csifcsak G, Bohne A, Pfuhl G, Rognmo K, Braarud HC, Goksoyr A, Moe V, Slinning K, Wang CEA. Newborn Behavioral Observation, maternal stress, depressive symptoms and the mother-infant relationship: results from the Northern Babies Longitudinal Study (NorBaby). BMC Psychiatry. 2020 Jun 15;20(1):300. doi: 10.1186/s12888-020-02669-y.

    PubMed 32539729
  • Hoifodt RS, Nordahl D, Pfuhl G, Landsem IP, Thimm JC, Ilstad LKK, Wang CEA. Protocol for the Northern babies longitudinal study: predicting postpartum depression and improving parent-infant interaction with The Newborn Behavioral Observation. BMJ Open. 2017 Sep 27;7(9):e016005. doi: 10.1136/bmjopen-2017-016005.

    PubMed 28963284

Questions about this trial

What is this clinical trial studying?

A study testing The Newborn Behavioral Observation (NBO) and Routine care in people with Depression, Postpartum, run by University of Tromso at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 May 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Levels of postpartum depression (time frame: Six weeks postpartum). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02538497, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 May 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in